James Oliver received an integrated master’s degree in Biochemistry and Genetics from the University of Sheffield and his Ph.D. from the University of Manchester at the Versus Arthritis Centre for Genetics and Genomics. His Ph.D. research was focused on identifying early gene expression biomarkers of response to adalimumab therapy in rheumatoid arthritis patients in order to guide treatment decisions. In 2017, he gained a place on the Scientist Training Programme and pursued training as a clinical scientist in genomics at the Leeds Teaching Hospitals NHS Trust. Following the recent completion of his training, he currently works as a registered clinical scientist in Leeds within the inherited cancer section. Outside work, James enjoys cooking, cinema, and spending time with friends and family.
RESEARCH
Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment
James Oliver et al.
Arthritis Research & Therapy 2021 23:80
Published on: 10th March 2021